Personalized 125I Seed Interstitial Brachytherapy for Patients Aged 80 Years and Over with Early Primary High-risk Non-melanoma Skin Cancer.
Liang YansongWang JuanZhang HongtaoLiu ZezhouSu XiaohuaZhao HuanfenZhao RongmeiYin JianqiPublished in: Current radiopharmaceuticals (2023)
PISI-BT could be an alternative treatment option in patients above 80 years old with early primary high-risk NMSC and comorbidities.